Nervgen Pharma Corp (NGEN.VN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [TSX Venture]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [TSX Venture]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 09-2020 | 06-2020 | 03-2020 | 12-2019 | 09-2019 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 7,656 | 3,456 | 2,512 | 4,106 | 6,273 |
| Receivables | 6 | 7 | 7 | 123 | 100 |
| TOTAL | $9,766 | $5,635 | $4,923 | $6,256 | $6,541 |
| Non-Current Assets | |||||
| PPE Net | 2 | 3 | 3 | N/A | N/A |
| Intangibles | 481 | 490 | 500 | 510 | 519 |
| TOTAL | $483 | $493 | $503 | $510 | $519 |
| Total Assets | $10,249 | $6,129 | $5,427 | $6,765 | $7,060 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 45 | 182 | 518 | 752 | 418 |
| Accrued Expenses | 106 | 216 | 87 | N/A | N/A |
| TOTAL | $324 | $547 | $728 | $924 | $574 |
| Non-Current Liabilities | |||||
| TOTAL | $0 | $0 | $0 | $0 | $0 |
| Total Liabilities | $324 | $547 | $728 | $924 | $574 |
| Shareholders' Equity | |||||
| Common Shares | 22,869 | 17,796 | 15,441 | 15,294 | 13,331 |
| Retained earnings | -17,750 | -15,617 | -12,995 | -11,136 | -8,248 |
| Other shareholders' equity | 4,807 | 3,402 | 2,253 | 1,684 | 1,404 |
| TOTAL | $9,926 | $5,581 | $4,699 | $5,842 | $6,487 |
| Total Liabilities And Equity | $10,249 | $6,129 | $5,427 | $6,765 | $7,060 |